Quipt Home Medical Confirms Receipt of Forager's Repetitive Undervalued Offer; Board Denounces Inferior Terms and Self-Serving Tactics

Stock Information for Quest Patent Research Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quest Patent Research Corp

Forager's 120% Premium for Quipt Would Set M&A Benchmark; Board's Inaction Erodes Shareholder IRR
Forager Sets the Record Straight on Recent Efforts to Acquire Quipt for an All-Cash Premium
Quipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in Revenue
Canadian Investment Regulatory Organization Trade Resumption - QIPT
Canadian Investment Regulatory Organization Trading Halt - QIPT
Forager Capital Management Submits Fully Financed Proposal to Acquire Quipt Home Medical for $3.10 Per Share in Cash
Quipt Home Medical Partners With Three Major Health Systems to Form Strategic Joint Venture
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.